Eicosapentaenoic acid lowers plasma and liver cholesterol levels in the presence of peroxisome proliferators-activated receptor alpha

This publication has 62 references indexed in Scilit:

• The inhibitory effect of polyunsaturated fatty acids on human CYP enzymes
  Life Sciences, 2006
• Mechanisms for the Hypotriglyceridemic Effect of Marine Omega-3 Fatty Acids
  The American Journal of Cardiology, 2006
• Coronary artery disease in the developing world
  American Heart Journal, 2004
• An Eicosapentaenoic Acid Supplement Versus Megestrol Acetate Versus Both for Patients With Cancer-Associated Wasting: A North Central Cancer Treatment Group and National Cancer Institute of Canada Collaborative Effort
  Journal of Clinical Oncology, 2004
• Polyunsaturated fatty acids decrease the expression of sterol regulatory element-binding protein-1 in CaCo-2 cells: effect on fatty acid synthesis and triacylglycerol transport
  Biochemical Journal, 2002
• Effects of Docosahexaenoic and Eicosapentaenoic Acid on Lipid Metabolism, Eicosanoid Production, Platelet Aggregation and Atherosclerosis in Hypercholesterolemic Rats
  Bioscience, Biotechnology, and Biochemistry, 1999
• Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice.
  Journal of Clinical Investigation, 1996
• Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor.
  Journal of Clinical Investigation, 1995
• A Novel Disease with Deficiency of Mitochondrial Very-Long-Chain Acyl-CoA Dehydrogenase
  Biochemical and Biophysical Research Communications, 1993
• Reduction of Plasma Lipids, Lipoproteins, and Apoproteins by Dietary Fish Oils in Patients with Hypertriglyceridemia
  New England Journal of Medicine, 1985